12/10
07:17 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Medium
Report
Collegium Pharmaceutical (NASDAQ:COLL) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
12/9
10:34 am
coll
Rating for COLL
Low
Report
Rating for COLL
12/9
10:34 am
coll
Rating for COLL
Low
Report
Rating for COLL
12/8
06:07 pm
coll
Collegium Pharmaceutical (NASDAQ:COLL) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
12/8
04:25 pm
coll
Collegium Pharmaceutical initiated with an Overweight at Barclays
Low
Report
Collegium Pharmaceutical initiated with an Overweight at Barclays
12/8
04:25 pm
coll
Collegium Pharmaceutical initiated with an Overweight at Barclays
Low
Report
Collegium Pharmaceutical initiated with an Overweight at Barclays
10/28
08:09 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
10/28
05:29 am
coll
Rating for COLL
Low
Report
Rating for COLL
10/28
05:29 am
coll
Rating for COLL
Low
Report
Rating for COLL